Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

2.85
+0.03001.06%
Post-market: 2.850.00000.00%19:30 EDT
Volume:2.83M
Turnover:7.99M
Market Cap:350.62M
PE:-3.14
High:2.88
Open:2.80
Low:2.72
Close:2.82
52wk High:5.17
52wk Low:1.69
Shares:123.03M
Float Shares:94.52M
Volume Ratio:1.27
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9085
EPS(LYR):-1.2666
ROE:-48.14%
ROA:-19.25%
PB:1.42
PE(LYR):-2.25

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 18

Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV)

TIPRANKS
·
Jun 12

C4 Therapeutics Reports 53% Response Rate for Cemsidomide at RP2D

MT Newswires Live
·
Jun 11

C4 Therapeutics presentation highlights cemsidomide development, targeted protein degrader pipeline strategy

Reuters
·
Jun 11

C4 Therapeutics says cemsidomide posts 53% response rate in Phase 1 relapsed/refractory multiple myeloma trial at 100 µg dose

Reuters
·
Jun 11

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

GlobeNewswire
·
Jun 11

C4 Therapeutics Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jun 02

Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)

TIPRANKS
·
May 30

BMS's Phase III Multiple Myeloma Data Impresses, Boosting C4 Therapeutics Shares

Deep News
·
May 30

C4 Therapeutics jumps after Bristol Myers myeloma data

TIPRANKS
·
May 29

CCCC AGM to Vote on RMB99 Billion Securitization, Capital Structure Changes

TIPRANKS
·
May 29

CCCC Sets Up RMB1 Billion Transportation Information Technology Fund as Connected Transaction

TIPRANKS
·
May 28

C4 Therapeutics joins TD Cowen Oncology Innovation Summit fireside chat

Reuters
·
May 20

C4 Therapeutics to Participate in Upcoming Conferences

GlobeNewswire
·
May 20

C4 Therapeutics grants new hire stock options for 85,480 shares under Nasdaq rule

Reuters
·
May 19

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 19

C4 Therapeutics Realigns Finance Leadership After Officer Departure

TIPRANKS
·
May 16

C4 Therapeutics names CFO Kendra Adams principal accounting officer, effective May 15

Reuters
·
May 16

C4 Therapeutics (CCCC) Q1 Loss Of US$25.1 Million Reinforces Profitability Concerns

Simply Wall St.
·
May 14